GreenPeptide Co., Ltd. reported non-consolidated earnings results for the six months ended September 30, 2016. For the period, the company reported net sales of ¥317 million against ¥415 million a year ago. Operating loss was ¥468 million against ¥606 million a year ago. Ordinary loss was ¥472 million against ¥593 million a year ago. Net income for the period was ¥476 million or ¥14.58 per share against ¥594 million or ¥23.50 per share a year ago. Loss before income taxes was ¥473,000 million against ¥593,957 million a year ago. Net cash used in operating activities was ¥544,165 million against ¥527,050 million a year ago. Purchase of property, plant and equipment was ¥71,699 million against ¥1,467 million a year ago. Purchase of intangible assets was ¥4,527 million against ¥250 million a year ago.

For the year ending March 31, 2017, the company expects net sales of ¥406 million, operating loss of ¥1,306 million, ordinary loss of ¥1,306 million and net loss of ¥1,308 million or ¥41.14 per share.